1.北京中医药大学 北京 100029
2.清华大学第一附属医院
李勋欣,女,在读硕士生
# 谷晓红,女,硕士,教授、主任医师,博士生导师,E-mail: guxh1003@126.com
纸质出版日期:2022-07-30,
收稿日期:2021-10-16,
移动端阅览
李勋欣, 梅沉成, 于河, 等. 彭建中教授运用肾病组方治疗慢性肾脏病的临床观察[J]. 现代中医临床, 2022,29(4):23-26.
Xunxin LI, Chencheng MEI, He YU, et al. Clinical observation of Prof. Peng Jianzhong’s application of nephrotic formulas in the treatment of chronic kidney disease[J]. Modern Chinese Clinical Medicine, 2022,29(4):23-26.
李勋欣, 梅沉成, 于河, 等. 彭建中教授运用肾病组方治疗慢性肾脏病的临床观察[J]. 现代中医临床, 2022,29(4):23-26. DOI: 10.3969/j.issn.2095-6606.2022.04.004.
Xunxin LI, Chencheng MEI, He YU, et al. Clinical observation of Prof. Peng Jianzhong’s application of nephrotic formulas in the treatment of chronic kidney disease[J]. Modern Chinese Clinical Medicine, 2022,29(4):23-26. DOI: 10.3969/j.issn.2095-6606.2022.04.004.
目的
2
观察彭建中教授运用肾病组方治疗慢性肾脏病的临床疗效。
方法
2
选取慢性肾脏病患者374例,予中药肾病组方治疗,不限制西医基础治疗,包括控制饮食、血糖、血压等。观察治疗前后血肌酐(Cr)、尿素氮(BUN)、尿酸(UA)、肾小球滤过率(GFR)、甘油三酯(TG)、总胆固醇(TC)、24 h尿蛋白定量、尿蛋白、尿隐血的变化。
结果
2
治疗后Cr、UA较治疗前均降低(
P
<
0.05),GFR较治疗前升高(
P
<
0.05),BUN治疗前后比较差异无统计学意义(
P
>
0.05)。TG、TC治疗前后比较差异均无统计学意义(
P
>
0.05)。治疗后24 h尿蛋白定量较治疗前降低(
P
<
0.05)。治疗后尿蛋白情况优于治疗前(
P
<
0.05),治疗后尿隐血情况优于治疗前(
P
<
0.05)。
结论
2
彭建中教授运用肾病组方治疗慢性肾脏病具有较好的临床疗效。
Objective
2
To observe the clinical efficacy of nephrotic formulas by Professor Peng Jianzhong for chronic kidney disease.
Methods
2
A total of 374 patients with chronic kidney disease were selected and treated with nephropathy formulas
without limiting the basic treatment of Western medicine
including diet
blood glucose and blood pressure. The changes in creatinine (Cr)
uric acid (UA)
urea nitrogen (BUN)
glomerular filtration rate (GFR)
triglyceride (TG)
total cholesterol (TC)
24-hour urine total protein quantification
urinary protein and urinary occult blood were observed before and after treatment.
Results
2
After treatment
Cr and UA decreased (
P
<
0.05) and GFR increased (
P
<
0.05)
and there was no significant difference before and after BUN treatment (
P
>
0.05). There was no significant difference in TG and TC before and after treatment (
P
>
0.05). The 24-hour urine total protein quantification was lower after treatment than before treatment (
P
<
0.05). The urinary protein after treatment was better than that before treatment (
P
<
0.05)
and the urinary occult blood after treatment was better than that before treatment (
P
<
0.05).
Conclusions
2
The nephrotic formulas that Professor Peng Jianzhong uses to treat chronic kidney disease have a good clinical effect.
慢性肾脏病观察性研究名医经验彭建中
chronic kidney diseaseobservational studyfamous physician’s experiencePeng Jianzhong
林果为,王吉耀,葛均波.实用内科学[M].北京:人民卫生出版社,2020:1940.
ZHANG L, WANG F, WANG L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey[J].Lancet, 2012,379(9818): 815-822.
刘洪,熊维建,罗浩轩,等.培元消癥方治疗慢性肾脏病5期透析合并CKD-MBD骨痛临床疗效研究[J].北京中医药大学学报,2021,44(7):650-658.
WU R, CHEN J, YE Z, et al. Research progress in the treatment of diabetic kidney disease with Chinese medicine enema[J].Journal of Traditional Chinese Medical Sciences, 2021,8(3):205-215.
王如梦,赵明明,张昱.从瘀论治IgA肾病的理论与经验[J].现代中医临床,2021,28(4):67-70.
彭建中.论同病同治——大法指导下的随证治之[J].中外医疗,2008,27(27):74-76.
上海慢性肾脏病早发现及规范化诊治与示范项目专家组.慢性肾脏病筛查诊断及防治指南[J].中国实用内科杂志,2017,37(1):28-34.
耿贤华,彭越,彭建中.彭建中教授辨治肾病十八法[J].光明中医,2021,36(9):1420-1423.
孙晓光,彭建中.赵绍琴慢性肾病辨治理论和经验的传承发展[J].世界中西医结合杂志,2015,10(3):321-322,356.
温娟,宋珍,彭越,等.彭建中辨治慢性肾功能不全经验[J].光明中医,2019,34(3):366-368.
耿贤华,彭越,彭建中.彭建中教授治肾病之凉血化瘀法[J].光明中医,2020,35(24):3884-3886.
耿贤华,彭越,彭建中.彭建中教授治肾病之疏风胜湿法[J].光明中医,2020,35(23):3709-3711.
耿贤华,彭越,彭建中.彭建中教授治肾病之益气培元法[J].光明中医,2020,35(18):2836-2838.
耿贤华,彭越,彭建中.彭建中教授治肾病之通腑排毒法[J].光明中医,2020,35(17):2666-2668.
耿贤华,彭建中.彭建中教授疏调三焦法治肾病经验[J].光明中医,2019,34(13):1964-1966.
李莉.连续性肾替代疗法治疗老年慢性肾功能不全合并多器官功能障碍的效果分析[J].当代医学,2022,28(3):51-53.
0
浏览量
25
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构